CHRISTINE MARTINDALE: Open Payments
NPI 1114933793 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 12 payments from 10 companies in 2025. Trend: 2023 $131 · 2024 $178 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $45 |
| Boston Scientific Corporation | 1 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| UROGEN PHARMA, INC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| 180 Medical, Inc. | 1 | $24 |
| TOLMAR, INC. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Calyxo, Inc. | 1 | $19 |
Products named: ORGOVYX, BOTOX, Rezum Generator, PLUVICTO, JELMYTO, Nubeqa, GENTLECATH, JATENZO.
Industry payments across DE — which companies pay providers there.
